The release of soluble inflammatory mediators such as CCL5, CXCL4, and CXCL7 by platelets induce the migration and activation of monocytes, dendritic cells and neutrophils to the damaged site, contributing to the progression of atherosclerosis (104). This evidence concerns the gene PF4 and atherosclerosis.